Session 5: Bridging clinic with biology: Emerging drugable pathways on the horizon

Chairs: Giuseppe Curigliano (Italy), Clifford Hudis (USA)

  • Targeting CDK 4-6 pathway (Richard S. Finn, USA)
  • Targeting DNA repair pathways (Andrew Tutt, United Kingdom)
  • Targeting PIK3CA pathway (José Baselga, USA)
  • Targeting FGFR pathway (Nicholas Turner, United Kingdom)
  • Discussion